Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Nov 1;184(11):1386-1388.
doi: 10.1001/jamainternmed.2024.4748.

Direct-to-Consumer Educational Brochures to Promote Gabapentinoid Deprescribing in Older Adults

Affiliations
Comment

Direct-to-Consumer Educational Brochures to Promote Gabapentinoid Deprescribing in Older Adults

Marc-Alexandre Gingras et al. JAMA Intern Med. .
No abstract available

Plain language summary

This study examines gabapentinoid deprescribing using a novel approach of direct-to-consumer educational brochures intended to empower older adults to initiate a discussion on gabapentinoid risks and tapering.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Lee reported receiving research salary support from Fonds de Recherche du Quebec–Sante and grants from the Canadian Institutes of Health outside the submitted work. Dr McDonald reported being the director of the Canadian Medication Appropriateness and Deprescribing Network, which developed the brochures tested in this study. No other disclosures were reported.

Comment on

References

    1. Wiffen PJ, Derry S, Bell RF, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6(6):CD007938. doi: 10.1002/14651858.CD007938.pub4 - DOI - PMC - PubMed
    1. Derry S, Cording M, Wiffen PJ, Law S, Phillips T, Moore RA. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev. 2016;9(9):CD011790. doi: 10.1002/14651858.CD011790.pub2 - DOI - PMC - PubMed
    1. Johansen ME. Gabapentinoid use in the United States 2002 through 2015. JAMA Intern Med. 2018;178(2):292-294. doi: 10.1001/jamainternmed.2017.7856 - DOI - PMC - PubMed
    1. Canadian Medication Appropriateness and Deprescibing Network . You may be at risk: gabapentinoids. Accessed June 20, 2024. https://www.deprescribingnetwork.ca/s/Gabapentinoids_EN_Brochure-86nw.pdf
    1. Williams J, Gingras MA, Dubé R, Lee TC, McDonald EG. Patient empowerment brochures to increase gabapentinoid deprescribing: protocol for the prospective, controlled before-and-after GABA-WHY trial. CMAJ Open. 2022;10(3):E652-E656. doi: 10.9778/cmajo.20210302 - DOI - PMC - PubMed